Life sciences frequently encounter tax issues in out-licensing their IP in collaboration with larger companies. These corporate tax issues have become more acute with recent changes to require capitalization of research and development expenses, such that more companies are lacking NOLs to shelter royalty income from corporate tax. This webinar will provide a primer on the key tax issues in structuring and planning for licensing and collaboration transactions, as well as related transactions, such as the “LLC Holdco Structure,” recent IRS rules on tax-free spin-offs, and royalty monetization transactions.